CosACTHen^® (cosyntropin injection)

​As with all drugs, side effects may occur. For intravenous or intramuscular use in dogs only. Use only in dogs older than 4 months of age and weighing greater than 10 lbs (4.5 kg). Do not use Cosacthen in dogs that have previously had a hypersensitivity reaction to cosyntropin. In the field study, two dogs vomited within 8 hours after cosyntropin administration, and one dog developed a hematoma at the injection site after IV administration. The following adverse events were reported voluntarily during postapproval use of Cosacthen in dogs in foreign markets: lethargy, anxiety, muscle tremor/weakness, abdominal pain, anorexia, diarrhea, injection site pain/bruising, lameness, and hypersensitivity reactions. The safe use of Cosacthen has not been evaluated in breeding, pregnant, or lactating dogs. Not for use in humans. Keep this and all drugs out of reach of children. People with known hypersensitivity to cosyntropin or ACTH should avoid contact with the product. Pregnant and breastfeeding women should take care to avoid accidental self-injection. If any anaphylactic or allergic symptoms develop following exposure to Cosacthen, or in case of accidental self-injection, seek medical advice immediately. If skin contact occurs, wash affected area with soap and water. Refer to the prescribing information for complete details or visit www.dechra‐us.com.